1Simopoulos, AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl., 560S–569S.
2Weber, PC, Fischer, S, von Schacky, C, et al. (1986) Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In Health Effects of Polyunsaturated Fatty Acids in Sea Foods, pp. 49–60 [, editors]. Orlando, FL: Academic Press.
3Ekema, G, Falchetti, D, Boroni, G, et al. (2008) Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J Pediatr Surg 43, 1191–1195.
4Eisner, F, Jacob, P, Frick, JS, et al. (2011) Immunonutrition with long-chain fatty acids prevents activation of macrophages in the gut wall. J Gastrointest Surg 15, 853–859.
5Meydani, SN, Lichtenstein, AH, Cornwall, S, et al. (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92, 105–113.
6Loeschke, K, Ueberschaer, B & Pietsch, A (1996) n-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41, 2087–2094.
7Aslan, A & Triadafilopoulos, G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87, 432–437.
8Kremer, JM, Lawrence, DA, Petrillo, GF, et al. (1995) Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates. Arthritis Rheum 38, 1107–1114.
9Geusens, P, Wouters, C, Nijs, J, et al. (1994) Long term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis: a 12 month, double blind, controlled study. Arthritis Rheum 37, 824–829.
10Schmöcker, C, Weylandt, KH, Kahlke, L, et al. (2007) Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 45, 864–869.
11Sonis, ST (1993) Complications of cancer and their treatment: oral complications. In Cancer Medicine, 3rd ed., pp. 2381–2388 [, editors]. Philadelphia: Lea and Febiger.
12Naidu, MU, Ramana, GV, Rani, PU, et al. (2004) Chemotherapy-induced and/or radiation therapy-induced oral mucositis? Complicating the treatment of cancer. Neoplasia 6, 423–431.
13Sonis, ST, Elting, LS, Keefe, DMK, et al. (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995–2025.
14Kesik, VUysal, B, Kurt, B, et al.
(2009) Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biol Ther 8, 1623–1628.
15Dyerberg, J, Bang, HO & Hjorne, N (1975) Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28, 958–967.
16Simopoulos, AP, Kifer, RR, Wykes, AA, et al. (1991) Omega 3 fatty acids: research advances and support in the field since June 1985 (worldwide). World Rev Nutr Diet 66, 51–71.
17Levy, AE & Alexander, JW (1995) Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and CsA. Transplantation 60, 812–815.
18Calder, PC, Yaqoob, P, Harvey, DJ, et al. (1994) The incorporation of fatty acids by lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 300, 509–518.
19Yaqoob, P, Newsholme, EA & Calder, PC (1995) Influence of cell culture conditions on diet-induced changes in lymphocyte fatty acid composition. Biochim Biophys Acta 1255, 333–340.
20Lewis, RA, Lee, TH & Austen, KF (1986) Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In Health Effects of Polyunsaturated Fatty Acids in Sea Foods, pp. 227–238 [, editors]. Orlando, FL: Academic Press.
21Shoda, R, Matsueda, K, Yamato, S, et al. (1995) Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 30, Suppl. 80, 98–101.
22Hillier, K, Jewell, R, Dorrell, L, et al. (1991) Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32, 1151–1155.
23Haegebarth, A & Clevers, H (2009) Wnt signaling, Lgr5, and stem cells in the intestine. Am J Pathol 174, 15–21.
24Sukhotnik, I, Mogilner, J, Karry, R, et al. (2009) Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in a rat. Digestion 79, 5–13.
25Sukhotnik, I, Mogilner, JG, Shteinberg, D, et al. (2009) Leptin accelerates enterocyte turnover during methotrexate-induced intestinal mucositis in a rat. Cancer Biol Ther 8, 1–7.
26Calder, PC (2009) Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol 28, 506–534.
27Calderaro, V, Parrillo, C, Balestrieri, ML, et al. (1994) Docosahexaenoic acid and signaling pathways in rabbit colon. Mol Pharmacol 45, 737–746.
28Pearson, G, Robinson, F, Beers Gibson, T, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22, 153–183.
29Logan, RM, Stringer, AM, Bowen, JM, et al. (2008) Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7, 1139–1145.